Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02785536 · ClinicalTrials.gov registry record · NA

RITCH: Reducing Disparities in Tobacco Cessation Outcomes

A NA study, sponsored by The City College of New York.

Completed
Registry status
NA
Development phase
256
Enrollment target

NCT02785536 is a NA study that has completed, run by The City College of New York. The registered enrollment target is 256 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02785536, a NA study, has completed, sponsored by The City College of New York.

COMPLETED
Registry status
NA
Development phase
256 participants
Enrollment target

Study Summary

Tobacco use is a leading contributor to racial and socioeconomic health disparities in the US primarily due to an unequal burden of tobacco-related disease from a disproportionate share of smokers in African American and lower socioeconomic (SES) groups. Unlike many other health risk behaviors, tobacco-related health disparities are increasing despite a large treatment network of free telephone and in-person counseling services, perhaps due to significant disparities in treatment outcomes. The goal of this project is to revise the standard treatment for tobacco dependence to address key factors associated with treatment outcome disparities and more fully meet the needs of lower SES and African American smokers thereby reducing socioeconomic disparities in tobacco dependence treatment outcomes, halting the alarming increase in tobacco-related health disparities, and reducing a leading cause of racial and socioeconomic health disparities in the US.

Interventions

  • BEHAVIORAL Standard Treatment
  • BEHAVIORAL RITCh Treatment

Trial Details

FieldValue
Enrollment Target 256 participants
Start Date 2013-07
Est. Completion 2015-06
Phase NA

Sponsor

The City College of New York

7 total trials

What the Registry Record Tells You About NCT02785536

The ClinicalTrials.gov registry entry for NCT02785536 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The City College of New York, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard Treatment is the first listed.

NCT02785536 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02785536 about?

NCT02785536 is a clinical study titled "RITCH: Reducing Disparities in Tobacco Cessation Outcomes". Tobacco use is a leading contributor to racial and socioeconomic health disparities in the US primarily due to an unequal burden of tobacco-related disease from a disproportionate share of smokers in African American and lower socioeconomic (SES) groups. Unlike many other health risk behaviors, toba...

What is the current status of trial NCT02785536?

This trial is currently completed. It is a NA study. The enrollment target is 256 participants. The study started on 2013-07. Estimated completion is 2015-06.

What interventions are being tested in trial NCT02785536?

The interventions under investigation include: Standard Treatment (BEHAVIORAL), RITCh Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT02785536?

This trial is sponsored by The City College of New York, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.